# RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.

> **NCT02247726** · PHASE2 · COMPLETED · sponsor: **Novavax** · enrollment: 50 (actual)

## Conditions studied

- Respiratory Syncytial Virus Infections

## Interventions

- **DRUG:** Saline Placebo (0.5mL injection)
- **DRUG:** RSV F vaccine (0.5mL injection)

## Key facts

- **NCT ID:** NCT02247726
- **Lead sponsor:** Novavax
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2022-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02247726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02247726, "RSV F Vaccine Maternal Immunization Study in Healthy Third-trimester Pregnant Women.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02247726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*